Regeneron Pharmaceuticals, Inc.
MX ˙ BMV ˙ US75886F1075
SecurityMX:REGN / Regeneron Pharmaceuticals, Inc.
InstitutionVeracity Capital LLC
Latest Disclosed Ownership5,553 shares
Latest Disclosed Value $ 4,290,473
Veracity Capital LLC reports 1.30% decrease in ownership of REGN / Regeneron Pharmaceuticals, Inc.

On April 9, 2026 - Veracity Capital LLC filed a 13F-HR form disclosing ownership of 5,553 shares of Regeneron Pharmaceuticals, Inc. (MX:REGN) valued at $4,290,473 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 5,626 shares of Regeneron Pharmaceuticals, Inc.. This represents a change in shares of -1.30% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-09 2026-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 5,553 -73 -1.30 4,290 -1.20 1.5328
2026-01-29 2025-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 5,626 4 0.07 4,343 37.36 1.2781
2025-10-08 2025-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 5,622 25 0.45 3,161 7.59 1.0082
2025-07-09 2025-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 5,597 -4 -0.07 2,938 -17.29 1.0055
2025-04-10 2025-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 5,601 -13 -0.23 3,552 -11.18 1.3758
2025-01-17 2024-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 5,614 -58 -1.02 3,999 -32.93 1.4430
2024-10-18 2024-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 5,672 -140 -2.41 5,963 -2.39 2.2598
2024-07-22 2024-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 5,812 -310 -5.06 6,109 3.67 2.5432
2024-04-19 2024-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 6,122 -241 -3.79 5,892 5.44 2.2887
2024-01-22 2023-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 6,363 -104 -1.61 5,588 5.00 2.2391
2023-10-25 2023-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 6,467 -51 -0.78 5,322 13.65 2.4694
2023-07-20 2023-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 6,518 17 0.26 4,683 -12.32 1.9872
2023-04-06 2023-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 6,501 -293 -4.31 5,342 8.98 2.4653
2023-01-17 2022-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 6,794 -145 -2.09 4,902 2.53 2.3497
2022-10-17 2022-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 6,939 2 0.03 4,780 16.56 2.6048
2022-07-18 2022-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 6,937 -110 -1.56 4,101 -16.68 2.1826
2022-04-18 2022-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 7,047 -221 -3.04 4,922 7.23 2.0446
2022-01-31 2021-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 7,268 37 0.51 4,590 4.89 1.8417
2021-10-13 2021-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 7,231 -530 -6.83 4,376 0.95 1.8765
2021-08-24 2021-06-30 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 7,761 -124 -1.57 4,335 16.19 1.0053
2021-07-22 2021-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 7,761 -124 4,335 1.7608
2021-09-10 2021-03-31 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 7,885 -703 -8.19 3,731 -10.07 1.7067
2021-04-12 2021-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 7,885 -703 3,731 1.4883
2021-09-10 2020-12-31 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 8,588 396 4.83 4,149 -9.53 2.1538
2021-01-25 2020-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 8,588 396 4,149 2.0094
2021-09-10 2020-09-30 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 8,192 161 2.00 4,586 -8.44 2.5745
2020-10-21 2020-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 8,192 161 4,586 2.4253
2021-09-10 2020-06-30 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 8,031 -8,205 -50.54 5,009 -36.82 2.8910
2020-07-13 2020-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 8,031 -8,205 5,009 2.7236
2020-05-07 2020-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 16,236 -1,086 -6.27 7,928 21.89 2.2897
2020-05-07 2019-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 17,322 17,322 6,504 1.6813
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.